Organization

Japan

In the news

EU Approves Etcamah in First-Line ER+ Breast Cancer

AstraZeneca’s Etcamah (camizestrant) won EU approval to be used with CDK4/6 inhibitors as a first-line treatment for ER-positive, HER2-negative advanced breast cancer in patients with ESR1 mutations, based on SERENA-6 trial results showing a 56% reduction in progression or death. The drug already has approvals in Japan, the UAE, and Saudi Arabia, with U.S. review ongoing and the EU decision highlighting its potential to expand AstraZeneca’s oncology footprint as it targets endocrine-resistant disease.

8 sources

South Korea completes ITER vacuum vessel sector module

The Korea-ITER Fusion Day marks the completion of the last vacuum vessel sector assembled by HD Hyundai and its integration into a sector module, moving toward a 5,000-ton donut-shaped vacuum vessel for the ITER reactor. HD Hyundai has produced four of the nine sectors, underscoring South Korea’s pivotal role and international collaboration in advancing fusion energy.

6 sources

Photo: Unknown authorUnknown author / Wikimedia Commons (CC0)

Stephens Greth Expands ETF Stakes Across VGK, EWJ

Stephens Greth Foundation continued expanding its ETF exposure, boosting its stake in Vanguard FTSE Europe ETF (VGK) to 581,343 shares—about a 376% increase—and signaling VGK as a top holding, while also increasing its position in iShares MSCI Japan ETF (EWJ) to 287,652 shares, a roughly 378% rise. The foundation’s activity spans VGK, EWJ, and Vanguard FTSE Emerging Markets ETF (VWO), reflecting a broader pattern of aggressive additions alongside other large investors across these funds.

5 sources

Articleresearching the web…

On IJR

No public IJR answers mention Japan yet. As people ask about it and share their answers, they'll appear here.